Bio-Techne Corporation (TECH)

CIK 0000842023 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q3-2026 8-K (2026-05-06) · 99.1 · 99.2
Q2-2026 8-K (2026-02-04) · 99.1 · 99.2
Q1-2026 8-K (2025-11-05) · 99.1 · 99.2
Latest FY-2025 8-K (2025-08-06) · 99.1 · 99.2
Q3-2025 8-K (2025-05-07) · 99.1 · 99.2
Q2-2025 8-K (2025-02-05) · 99.1 · 99.2 · 99.3
Q1-2025 8-K (2024-10-30) · 99.1 · 99.2
FY-2024 8-K (2024-08-07) · 99.1 · 99.2
Q3-2024 8-K (2024-05-01) · 99.1 · 99.2
Q2-2024 8-K (2024-02-01) · 99.1 · 99.2
Q1-2024 8-K (2023-10-31) · 99.1 · 99.2
FY-2023 8-K (2023-08-08) · 99.1 · 99.2

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Consolidated Statements of Earnings and Comprehensive Income
Consolidated Balance Sheets
Consolidated Statements of Earnings and Comprehensive Income (P)
Consolidated Balance Sheets (P)
Condensed Consolidated Statements of Shareholders' Equity
—
Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Stockholders' Equity
—
Condensed Consolidated Statements of Stockholders' Equity (P)
—
Consolidated Statements of Shareholders' Equity (P)
—
Notes
Acquisitions
Basis of Presentation and Summary of Significant Accounting Policies
—
Cybersecurity Risk Management and Strategy Disclosure
—
Debt and Other Financing Arrangements
Description of Business and Summary of Significant Accounting Policies
—
Description of Business and Summary of Significant Accounting Policies:
—
Earnings Per Share
Fair Value Measurements
Income Taxes
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Leases
Other Income / (expense)
Pay Vs Performance Disclosure
Restructurings
Revenue Recognition
Segment Information
Selected Balance Sheet Data
—
Share-based Compensation
—
Share-based Compensation and Other Benefit Plans
—
Subsequent Events
Supplemental Balance Sheet and Cash Flow Information
—
Supplemental Equity and Accumulated Other Comprehensive Income (loss)
—
Supplemental Equity and Accumulated Other Comprehensive Income (loss) Information